Mitoxantrone dihydrochloride, an FDA approved drug, binds with SARS-CoV-2 NSP1 C-terminal

Kumar P., Bhardwaj T., Giri R.

SARS-CoV-2 NSP1 is believed to be a potential drug target. Its C-terminal region which associates with ribosomal subunit has shown good binding with an anticancer drug, Mitoxantrone.

DOI

10.1039/d1ra07434b

Type

Journal article

Publisher

Royal Society of Chemistry (RSC)

Publication Date

2022-01-01T00:00:00+00:00

Volume

12

Pages

5648 - 5655

Total pages

7

Permalink More information Close